Hashimoto's Thyroiditis
Conditions
Interventions
Experimental group:External application of Xiao Ying San Jie Fang
Control group:Placebo
Sponsors
Dongfang Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with normal thyroid function who meet the diagnostic criteria of Hashimoto's thyroiditis in western medicine; 2. Accords with TCM syndrome differentiation and belongs to qi stagnation and phlegm obstruction syndrome; 3. Aged 18-70 years; 4. Participated in this study voluntarily, with good compliance and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who have recently taken traditional Chinese medicine preparations for treating thyroiditis of qi stagnation and phlegm stagnation type; 2. Pregnant or lactating women; 3. Patients with serious primary diseases and mental diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; 4. Patients with thyroid cancer and unexplained fever; 5. Patients allergic to the experimental drug; 6. Patients who have participated in clinical trials of other drugs in recent 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate of efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score;TG-Ab, TPO-Ab; | — |
Countries
China
Contacts
Public ContactHu Hao
Dongfang Hospital Beijing University of Chinese Medicine
Outcome results
None listed